Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · IEX Real-Time Price · USD
2.130
+0.060 (2.90%)
At close: Mar 28, 2024, 3:49 PM
2.250
+0.120 (5.63%)
After-hours: Mar 28, 2024, 7:57 PM EDT

Bone Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2007
Net Income
-8.95-1.48-1.61-1.82-3.42-4.43-7.05-25.88-13.88-4.42
Upgrade
Depreciation & Amortization
0000000000
Upgrade
Share-Based Compensation
0.150.270.2100.15-0.61-0.589.553.70.26
Upgrade
Other Operating Activities
-0.76-2.350.181.40.020.934.3196.631.41
Upgrade
Operating Cash Flow
-9.56-3.57-1.23-0.43-3.25-4.1-3.33-7.33-3.55-2.76
Upgrade
Capital Expenditures
00000000-0-0.01
Upgrade
Change in Investments
0000000000.04
Upgrade
Investing Cash Flow
00000000-00.03
Upgrade
Share Issuance / Repurchase
5.044.436.86004.370.73.7500.48
Upgrade
Debt Issued / Paid
001.050.42.3202.73.0824.91
Upgrade
Financing Cash Flow
5.044.437.90.42.324.373.46.8325.39
Upgrade
Net Cash Flow
-4.510.866.68-0.02-0.930.270.07-0.49-1.552.66
Upgrade
Free Cash Flow
-9.56-3.57-1.23-0.43-3.25-4.1-3.33-7.33-3.55-2.77
Upgrade
Free Cash Flow Per Share
-36.31-74.84-64.92-35.20-267.57-490.07-513.21-1168.40-747.58-1110.56
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).